Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Why universities should step up in venture investing

Nature Biotechnology volume 30, pages 933–936 (2012)Cite this article

Subjects

University funds have a unique opportunity to bridge the gap to commercialization.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The total funds invested and deals made per year in biotech companies by US venture capital groups.

References

  1. Kneller, R. Nat. Rev. Drug Discov. 9, 867–882 (2010)

    Article  CAS  Google Scholar 

  2. National Venture Capital Association. Venture capital firms raise $5.6B in fourth quarter 2011 as industry continues to consolidate (Thomson Reuters news release, 9 January 2012).

  3. National Venture Capital Association. Venture capital investments experience double-digit increases in dollars and deal volume in Q2 2012: internet-specific and early stage investing jumps; life sciences investing falls (Thomson Reuters news release, 20 July 2012).

  4. Booth, B.L. Nat. Biotechnol. 27, 705–709 (2009).

    Article  CAS  Google Scholar 

  5. Booth, B.L. & Salehizadeh, B. Nat. Biotechnol. 29, 579–583 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia,, Pennsylvania, USA

    Amanda Christini

Authors
  1. Amanda Christini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amanda Christini.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christini, A. Why universities should step up in venture investing. Nat Biotechnol 30, 933–936 (2012). https://doi.org/10.1038/nbt.2390

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2390

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research